Bell Biosystems, Inc. is a biotechnology company based in San Francisco that is currently developing tracking technologies for the cell therapy industry. The core product is the Magnelle, which is a cell tracking solution that allows transplanted cells to be visualized using standard magnetic resonance imaging (MRI). The ultimate goal is to advance cell therapy treatments for neurodegenerative, cardiovascular, and other diseases.
Area of focus: Platform/research tool
Commencement Date: October 30, 2013
Location: JLABS @ QB3